375 related articles for article (PubMed ID: 22289720)
1. Epigenetic biomarkers in skin cancer.
Greenberg ES; Chong KK; Huynh KT; Tanaka R; Hoon DS
Cancer Lett; 2014 Jan; 342(2):170-7. PubMed ID: 22289720
[TBL] [Abstract][Full Text] [Related]
2. Epigenetics of cutaneous T-cell lymphoma: biomarkers and therapeutic potentials.
Lai P; Wang Y
Cancer Biol Med; 2021 Feb; 18(1):34-51. PubMed ID: 33628583
[TBL] [Abstract][Full Text] [Related]
3. CpG island methylator phenotype predicts progression of malignant melanoma.
Tanemura A; Terando AM; Sim MS; van Hoesel AQ; de Maat MF; Morton DL; Hoon DS
Clin Cancer Res; 2009 Mar; 15(5):1801-7. PubMed ID: 19223509
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma.
Nguyen T; Kuo C; Nicholl MB; Sim MS; Turner RR; Morton DL; Hoon DS
Epigenetics; 2011 Mar; 6(3):388-94. PubMed ID: 21081840
[TBL] [Abstract][Full Text] [Related]
5. Melanoma epigenetics: novel mechanisms, markers, and medicines.
Lee JJ; Murphy GF; Lian CG
Lab Invest; 2014 Aug; 94(8):822-38. PubMed ID: 24978641
[TBL] [Abstract][Full Text] [Related]
6. AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome.
Hoshimoto S; Kuo CT; Chong KK; Takeshima TL; Takei Y; Li MW; Huang SK; Sim MS; Morton DL; Hoon DS
J Invest Dermatol; 2012 Jun; 132(6):1689-97. PubMed ID: 22402438
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation in human melanoma: past and future.
Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
[TBL] [Abstract][Full Text] [Related]
8. DSS1 promoter hypomethylation and overexpression predict poor prognosis in melanoma and squamous cell carcinoma patients.
Venza M; Visalli M; Catalano T; Beninati C; Teti D; Venza I
Hum Pathol; 2017 Feb; 60():137-146. PubMed ID: 27825810
[TBL] [Abstract][Full Text] [Related]
9. Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma.
Pogribny IP; Rusyn I
Cancer Lett; 2014 Jan; 342(2):223-30. PubMed ID: 22306342
[TBL] [Abstract][Full Text] [Related]
10. Circulating epigenetic biomarkers in melanoma.
Xin Y; Li Z; Chan MT; Wu WK
Tumour Biol; 2016 Feb; 37(2):1487-92. PubMed ID: 26662802
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic regulation of microRNA genes and the role of miR-34b in cell invasion and motility in human melanoma.
Mazar J; Khaitan D; DeBlasio D; Zhong C; Govindarajan SS; Kopanathi S; Zhang S; Ray A; Perera RJ
PLoS One; 2011; 6(9):e24922. PubMed ID: 21949788
[TBL] [Abstract][Full Text] [Related]
12. Higher methylation subtype of malignant melanoma and its correlation with thicker progression and worse prognosis.
Yamamoto Y; Matsusaka K; Fukuyo M; Rahmutulla B; Matsue H; Kaneda A
Cancer Med; 2020 Oct; 9(19):7194-7204. PubMed ID: 32406600
[TBL] [Abstract][Full Text] [Related]
13. Novel DNA methylation markers with potential prognostic relevance in advanced malignant melanoma identified using COBRA assays.
Kaehler KC; Politz O; Henderson D; Ulbrich HF; Hauschild A; Mund C; Egberts F
Melanoma Res; 2015 Jun; 25(3):225-31. PubMed ID: 25919928
[TBL] [Abstract][Full Text] [Related]
14. Analyzing the cancer methylome through targeted bisulfite sequencing.
Lee EJ; Luo J; Wilson JM; Shi H
Cancer Lett; 2013 Nov; 340(2):171-8. PubMed ID: 23200671
[TBL] [Abstract][Full Text] [Related]
15. Update on melanoma epigenetics.
de Unamuno B; Palanca S; Botella R
Curr Opin Oncol; 2015 Sep; 27(5):420-6. PubMed ID: 26197354
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer.
Durante G; Broseghini E; Comito F; Naddeo M; Milani M; Salamon I; Campione E; Dika E; Ferracin M
Expert Rev Mol Diagn; 2022 Mar; 22(3):305-318. PubMed ID: 35235479
[TBL] [Abstract][Full Text] [Related]
17. Epigenetics and cutaneous neoplasms: from mechanism to therapy.
Gibson F; Hanly A; Fisher R; Wyant WA; Wu M; Collard M; Alani RM
Epigenomics; 2023 Feb; 15(3):167-187. PubMed ID: 37020393
[TBL] [Abstract][Full Text] [Related]
18. Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities.
Micevic G; Theodosakis N; Bosenberg M
Clin Epigenetics; 2017; 9():34. PubMed ID: 28396701
[TBL] [Abstract][Full Text] [Related]
19. High-frequency p16(INK) (4A) promoter methylation is associated with histone methyltransferase SETDB1 expression in sporadic cutaneous melanoma.
Kostaki M; Manona AD; Stavraka I; Korkolopoulou P; Levidou G; Trigka EA; Christofidou E; Champsas G; Stratigos AJ; Katsambas A; Papadopoulos O; Piperi C; Papavassiliou AG
Exp Dermatol; 2014 May; 23(5):332-8. PubMed ID: 24673285
[TBL] [Abstract][Full Text] [Related]
20. Aberrant DNA methylation in cutaneous malignancies.
van Doorn R; Gruis NA; Willemze R; van der Velden PA; Tensen CP
Semin Oncol; 2005 Oct; 32(5):479-87. PubMed ID: 16210089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
